Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback